We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Muscle mass loss in patients with metastatic breast cancer.
- Authors
Solomayer, Erich-Franz; Braun, Eva-Marie; Zimmermann, Julia Sarah Maria; Radosa, Julia Caroline; Stroeder, Jonas; Endrikat, Jan; Gerlinger, Christoph
- Abstract
<bold>Purpose: </bold>To assess the change of body mass index (BMI), muscle mass, visceral and subcutaneous fat in patients with metastatic breast cancer.<bold>Methods: </bold>In this retrospective chart analysis, patients with metastatic breast cancer as initial diagnosis between 2012 and 2016 were analyzed. Patients had received either chemotherapy (CTH) or endocrine therapy (ETH) according to the German S3 Guideline. BMI was calculated from the patients' weight and height. Change of muscle mass, visceral and subcutaneous fat was determined by comparing the surface area of these tissues on transverse CT images at the level of the third lumbar vertebrae (L3) at baseline and during treatment.<bold>Results: </bold>A total of 45 patients were included in the study, 29 on CTH and 16 on ETH. BMI, visceral and subcutaneous fat remained stable over time for both treatment groups. When taking both treatment groups together, muscle mass decreased significantly by 5.0 ± 2.5 cm2 per year (p < 0.05).<bold>Conclusion: </bold>In patients with metastatic breast cancer, a slight reduction of muscle mass was observed, independent of therapy regimes.
- Subjects
BREAST tumors; METASTASIS; BODY mass index; SARCOPENIA; RETROSPECTIVE studies; DISEASE complications
- Publication
Archives of Gynecology & Obstetrics, 2019, Vol 299, Issue 5, pN.PAG
- ISSN
0932-0067
- Publication type
journal article
- DOI
10.1007/s00404-019-05168-y